Henry Schein HSIC US — Revenue

Similar metrics at other companies

DEUS — Revenue

$7.2B+3.9%

NTAPUS — Revenue

$902M+10.1%

OBAIUS — Revenue

$2.34M+4.5%

KEE

KEELUS — Revenue

$19.38M+4.6%

AMBAUS — Revenue

$1.92M+25.4%

WORUS — Revenue

$222.86M-3.5%

FAQ

What is Henry Schein's US — revenue?

Henry Schein (HSIC) reported US — revenue of $2.27B in Q4 2025.

How has Henry Schein's US — revenue changed year-over-year?

Henry Schein's US — revenue increased by 3.1% year-over-year, from $2.21B to $2.27B.

What is the long-term trend for Henry Schein's US — revenue?

Over 4 years (2021 to 2025), Henry Schein's US — revenue has grown at a 1.1% compound annual growth rate (CAGR), from $8.72B to $9.1B.

What does US — revenue mean?

This metric represents the total gross revenue generated from the sale of healthcare products and services within the United States geographic segment, excluding any taxes collected from customers. It serves as a primary indicator of the company's market penetration and demand for its dental and medical distribution offerings in the domestic market. This figure reflects the core top-line performance of the US business unit before accounting for operational expenses.